| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Loewald
CEO | Chief Executive Officer | 63 | 07/09/2020 |
Robert Green
DFI | Director of Finance/CFO | 54 | 01/01/2020 |
Matthew Bio
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Wayne Hewett
CHM | Chairman | 61 | 01/12/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.08% | - | - | 202.31Cr | ||
| +0.85% | -0.80% | +54.84% | +163.70% | 1,05100Cr | ||
| +1.23% | -1.53% | +55.26% | +59.07% | 61TCr | ||
| +0.04% | +2.58% | +32.96% | +88.75% | 45TCr | ||
| +0.78% | -0.71% | +30.04% | +24.61% | 33TCr | ||
| +1.41% | +0.58% | +33.92% | +47.20% | 28TCr | ||
| -0.27% | -1.87% | +22.13% | +23.47% | 26TCr | ||
| -1.76% | +2.37% | -22.19% | -38.45% | 22TCr | ||
| -1.42% | +0.80% | +22.81% | +60.77% | 20TCr | ||
| -1.48% | +3.43% | +23.42% | +73.31% | 17TCr | ||
| Average | -0.11% | +0.54% | +28.13% | +55.82% | 39.72TCr | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
Employees
-
Sector
Pharmaceuticals
















